Live Breaking News & Updates on Stockholm Stock Exchange Immu

Stay updated with breaking news from Stockholm stock exchange immu. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Mendus to participate in several investor and industry

Press release Stockholm, Sweden, January 8, 2024 Mendus AB ( ....

United States , San Francisco , Erik Manting , Healthcare Conference , Annual Lifesci Partners Corporate Access , Lifesci Corporate Access , Nasdaq Stockholm , Stockholm Stock Exchange Immu , Mendus Ab ,

Mendus Phase 1 vididencel clinical trial results in AML and

Press Release Stockholm, Sweden, November 3, 2023 Mendus Phase 1 vididencel clinical trial results in AML and high-risk MDS patients published in. ....

United States , Noord Holland , Erik Manting , Cancer Center Amsterdam , American Society Of Hematology , Erasmus University Medical Center , High Risk Myelodysplastic Syndrome , Acute Myeloid Leukemia Patients Receiving , Principal Investigator , Jeroen Rovers , Chief Medical Officer , Nasdaq Stockholm , American Society , Orphan Drug Designation , Fast Track Designation , Northx Biologics , Stockholm Stock Exchange Immu , Mendus Ab ,

Mendus AB: Notice of Extraordinary General Meeting in

The shareholders of Mendus AB (publ) (the “Company”), reg. no 556629-1786, are hereby invited to the Extraordinary General Meeting (“EGM”) on Monday, 10. ....

Corey Davis , Mario Brkulj , Erik Manting , European Parliament , Swedish Companies , Swedish Companies Registration Office , Valency Communications , Companies Registration Office , Lifesci Advisors , Extraordinary General Meeting , Euroclear Sweden , General Data Protection Regulation , Mats Dahlberg , Advokatfirman Delphi , Rights Issue , Registration Office , Swedish Companies Act , Flerie Invest , Pareto Securities , Sci Advisors , Stockholm Stock Exchange Immu , Mendus Ab ,

Mendus to participate in upcoming conferences in June 2023

Mendus AB (“Mendus” publ; IMMU.ST), a biopharmaceutical company focused on immunotherapies addressing tumor recurrence, today announced its participation. ....

United States , Corey Davis , Mario Brkulj , Erik Manting , Valency Communications , International Convention , Lifesci Advisors , Sci Advisors , Nasdaq Stockholm , Stockholm Stock Exchange Immu , Mendus Ab ,

Mendus AB: Change in number of shares and votes in Mendus

During March, the number of shares and votes in Mendus AB (publ) has changed as a result of 1,137,790 new shares being issued to Negma Group upon. ....

Erik Manting , Mario Brkulj , Corey Davis , Negma Group , Lifesci Advisors , Valency Communications , During March , Swedish Financial Instruments Trading Act , Sci Advisors , Nasdaq Stockholm , Stockholm Stock Exchange Immu , Mendus Ab ,